Basic Information
| LncRNA/CircRNA Name | PART1 |
| Synonyms | NA |
| Region | GRCh38_5:60487713-60547657 |
| Ensemble | ENSG00000152931 |
| Refseq | NR_024617 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR etc. |
| Sample | NSCLC tissues |
| Expression Pattern | up-regulated |
| Function Description | the expression of PART1 was significantly up-regulated in 73.1% (152/208) stage I-III NSCLC specimens compared with adjacent normal tissues. high tissue PART1 expression indicated poor DFS in stage I-III NSCLC patients. PART1 may prove to be a promising biomarker for prediction of survival and tumor recurrence in stage I-III NSCLC. |
| Pubmed ID | 28819376 |
| Year | 2017 |
| Title | PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer. |
External Links
| Links for PART1 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |